Fiveable

๐Ÿฆ Virology Unit 10 Review

QR code for Virology practice questions

10.1 Mechanisms of viral entry and uncoating

๐Ÿฆ Virology
Unit 10 Review

10.1 Mechanisms of viral entry and uncoating

Written by the Fiveable Content Team โ€ข Last updated September 2025
Written by the Fiveable Content Team โ€ข Last updated September 2025
๐Ÿฆ Virology
Unit & Topic Study Guides

Viruses have evolved clever ways to sneak into our cells. They latch onto specific receptors, hitch a ride through the cell membrane, and then shed their outer layers. It's like a molecular heist, with viruses using our own cellular machinery against us.

Once inside, viruses unpack their genetic cargo, ready to hijack our cells. This process varies between enveloped and non-enveloped viruses, influencing how they spread and survive. Understanding these entry tricks is key to stopping viral invasions.

Viral Entry Mechanisms

Attachment and Receptor Interactions

  • Viral attachment involves specific interactions between viral surface proteins (ligands) and host cell receptors, initiating the entry process
  • Viruses exploit existing cellular uptake pathways (clathrin-mediated endocytosis, caveolin-dependent endocytosis)
  • Some viruses induce macropinocytosis where cell membrane ruffles and engulfs large volumes of extracellular fluid containing viral particles
  • Choice of entry mechanism depends on virus structure, host cell type, and environmental factors
  • Examples of viral ligands include:
    • Hemagglutinin in influenza viruses
    • Spike protein in coronaviruses
  • Host cell receptors examples:
    • ACE2 for SARS-CoV-2
    • CD4 for HIV

Endocytosis and Membrane Fusion

  • Endocytosis internalizes virus within a vesicle, often triggered by receptor binding
  • Membrane fusion utilized by enveloped viruses merges viral envelope with host cell membrane
  • Direct penetration used by some viruses injects genetic material through cell membrane without full internalization
  • Endocytosis pathways include:
    • Clathrin-mediated endocytosis (influenza virus)
    • Caveolin-dependent endocytosis (SV40 virus)
  • Membrane fusion examples:
    • HIV uses gp41 protein for fusion at the cell surface
    • Influenza virus fuses within endosomes after pH-induced conformational changes

Uncoating and Genetic Material Release

Uncoating Process and Mechanisms

  • Uncoating releases viral genome from protective capsid into host cell cytoplasm or nucleus
  • Enveloped viruses begin uncoating with fusion of viral envelope with cellular membranes, exposing nucleocapsid
  • Non-enveloped viruses undergo conformational changes from cellular triggers, leading to capsid destabilization and genome release
  • Endosomal acidification triggers conformational changes in viral proteins, crucial for many uncoating processes
  • Some viruses use host cell proteases to degrade capsid proteins, facilitating genome release
  • Uncoating may occur in stages:
    • Partial disassembly at cell surface or in endosomes
    • Complete genome release in cytoplasm or nucleus

Timing and Cellular Factors

  • Timing and location of uncoating critical for successful viral replication
  • Uncoating process influences host's ability to detect and respond to infection
  • Cellular factors involved in uncoating:
    • pH changes in endosomes (influenza virus)
    • Cellular chaperones (adenovirus)
    • Proteasome activity (reovirus)
  • Examples of uncoating locations:
    • Poliovirus uncoats in the cytoplasm
    • Herpesvirus uncoats at the nuclear pore

Enveloped vs Non-enveloped Entry

Structural Differences and Entry Strategies

  • Enveloped viruses possess lipid bilayer from host cell membranes, non-enveloped viruses lack outer membrane
  • Enveloped viruses enter through membrane fusion at cell surface or within endosomes, using viral fusion proteins
  • Non-enveloped viruses enter through endocytosis followed by membrane penetration or pore formation in endosomal membrane
  • Enveloped viruses exploit cellular membrane fusion machinery
  • Non-enveloped viruses rely on capsid protein conformational changes for entry
  • Examples of enveloped viruses:
    • Influenza virus
    • HIV
    • Coronavirus
  • Examples of non-enveloped viruses:
    • Adenovirus
    • Poliovirus
    • Rotavirus

Uncoating and Environmental Stability

  • Enveloped virus uncoating begins with envelope fusion
  • Non-enveloped viruses require more extensive capsid disassembly for uncoating
  • Enveloped viruses more susceptible to environmental factors and disinfectants due to lipid envelope
  • Non-enveloped viruses tend to be more stable in various environments
  • Both types can use receptor-mediated endocytosis, but subsequent steps in cell entry and uncoating differ significantly
  • Environmental stability examples:
    • Influenza virus (enveloped) survives on surfaces for hours
    • Norovirus (non-enveloped) can persist for weeks on surfaces

Host Cell Receptors and Tropism

Receptor Function and Viral Tropism

  • Host cell receptors are specific molecules on cell surface that viruses recognize and bind to, initiating entry process
  • Distribution and abundance of specific receptors on different cell types determine viral tropism, influencing infectable tissues
  • Receptor binding often triggers conformational changes in viral proteins, facilitating subsequent entry steps
  • Some viruses use multiple receptors or co-receptors, affecting ability to infect different cell types or species
  • Affinity and specificity of virus-receptor interactions influence efficiency of viral entry and overall infection course
  • Examples of receptor-mediated tropism:
    • HIV targets CD4+ T cells using CD4 and chemokine receptors
    • Hepatitis B virus targets liver cells using sodium taurocholate cotransporting polypeptide (NTCP)

Evolutionary Aspects and Therapeutic Implications

  • Evolutionary changes in viral surface proteins can alter receptor usage, potentially changing host range or tissue tropism
  • Understanding virus-receptor interactions crucial for developing antiviral strategies (entry inhibitors, receptor decoys)
  • Receptor binding sites often conserved, making them potential targets for broad-spectrum antivirals
  • Examples of receptor-based antiviral strategies:
    • Maraviroc blocks HIV entry by targeting CCR5 co-receptor
    • Neutralizing antibodies against viral attachment proteins (influenza hemagglutinin)